Brand-name TECFIDERA offers your patients:

Access to therapy right
out of the gate

Explore access and reimbursement

Support services to help patients start and
continue on TECFIDERA

Explore support services

Clinical trial and
additional experience

Explore data

Over a Decade of Experience1,2

#1 prescribed oral RMS therapy in the US since September 2013*

>445,000
patients around the world have been treated with TECFIDERA

>875,000
global patient-years
of experience

>12 years
of combined clinical trial
and real-world experience

*As of June 16, 2020. Based on prescriptions since September 27, 2013.
This includes clinical trial use and patients prescribed TECFIDERA.